Therefore, normalized expression changes of IL1β at the end of surgery in combination with those of IL10 at the end of surgery and one day after surgery potentially distinguish between patients in risk of developing SIRS and those that recover normally from surgery. The gene discussed is IL1B; the disease is systemic inflammatory response syndrome.